PDL BioPharma, Inc. (NASDAQ:PDLI)

CAPS Rating: 3 out of 5

A biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life-threatening illnesses.

Results 1 - 20 of 129 : 1 2 3 4 5 6 7 Next »

Recs

0
Member Avatar bIlluminati (30.72) Submitted: 11/21/2014 3:04:21 PM : Underperform Start Price: $7.72 PDLI Score: -2.04

Patents running out.

Recs

0
Member Avatar Reddragyn (69.50) Submitted: 11/1/2014 1:15:10 PM : Outperform Start Price: $8.36 PDLI Score: -7.78

MagInvPlus

Recs

0
Member Avatar TrackMagicFormul (88.99) Submitted: 10/8/2014 10:15:20 AM : Outperform Start Price: $7.02 PDLI Score: -28.91

Investors should consider selling puts. You can achieve some very high annualized returns at strikes significantly below the current price. e.g.

Nov 14 $6.00 strike at 15¢ has 21% discount and 20% annualized return.

Recs

0
Member Avatar aa119634 (35.67) Submitted: 9/24/2014 12:43:14 PM : Outperform Start Price: $7.49 PDLI Score: +1.25

On-going royalties of .60 per share should be maintainable. With no price appreciation you earn 7.8% just sitting with the stock. If it gets close to 9 consider selling and buying back again if it gets under 8.

Recs

0
Member Avatar johnclanaro (< 20) Submitted: 8/19/2014 8:47:46 PM : Outperform Start Price: $9.29 PDLI Score: -18.96

2d qtr beats on eps, beats on revenue. yields 6.44% at a price of 9.55 per share.

Recs

0
Member Avatar Cabzx (54.09) Submitted: 8/17/2014 1:43:15 PM : Outperform Start Price: $9.16 PDLI Score: -18.50

The large Debt/Equity maybe a turnoff for some, but the company has solid revenues, consistently beating the industry. It has a very high coverage and makes for a consistent buy.

Recs

0
Member Avatar Orthonormal (90.58) Submitted: 3/12/2014 10:32:22 AM : Outperform Start Price: $7.79 PDLI Score: -9.27

Magic Formula pick 3/21/2012
renewed 3/12/2014

Recs

0
Member Avatar NorbertV (< 20) Submitted: 1/28/2014 5:12:41 PM : Outperform Start Price: $8.38 PDLI Score: -21.80

2 years 33% gain plus excellent dividend. P/E at 5 right now no reason it shouldn't continue up.

Recs

0
Member Avatar TheValueDude (23.40) Submitted: 1/9/2014 5:27:33 PM : Outperform Start Price: $8.09 PDLI Score: -14.56

Screen: Under $10B, Top 10% EBIT/EV, Z Score >1.81

Recs

0
Member Avatar lnlrmtg (31.17) Submitted: 1/8/2014 2:31:12 AM : Outperform Start Price: $8.13 PDLI Score: -15.30

fundamentals

Recs

0
Member Avatar Haugurafpeningum (28.69) Submitted: 1/5/2014 2:24:06 PM : Outperform Start Price: $8.11 PDLI Score: -15.07

porte and zz 1

Recs

0
Member Avatar Stregachess (< 20) Submitted: 10/3/2013 12:07:46 AM : Underperform Start Price: $7.34 PDLI Score: +14.58

Analyst love this stock but the IP can't be controlled they are in for a rough ride. Without patent protection it's all just a dream.

Recs

0
Member Avatar tgainesphd (67.62) Submitted: 4/18/2013 8:01:13 PM : Outperform Start Price: $6.65 PDLI Score: -14.86

Good growth potential.

Recs

0
Member Avatar Aquinas31 (36.80) Submitted: 4/3/2013 4:56:19 PM : Outperform Start Price: $6.51 PDLI Score: -11.55

Dividends going up, probably hits 8+ by 4th quarter

Recs

0
Member Avatar dunloggin (66.16) Submitted: 2/5/2013 1:45:05 PM : Outperform Start Price: $5.91 PDLI Score: -3.13

Dividend paying stock.

Recs

1
Member Avatar pavlos1971 (99.49) Submitted: 1/2/2013 3:58:59 PM : Underperform Start Price: $5.28 PDLI Score: +6.08

Short in RL@7.31

Recs

0
Member Avatar pdhaag (71.07) Submitted: 10/15/2012 9:18:41 PM : Underperform Start Price: $6.96 PDLI Score: +28.81

Most of it's patents are set to expire between 2014 and 2017, at which point revenue will drop dramatically. It's only a matter of time.

Recs

1
Member Avatar FoxForce5contest (< 20) Submitted: 8/18/2012 9:18:30 PM : Outperform Start Price: $6.16 PDLI Score: -17.21

on 8-18-12 Momentum21 picked PDLI

Recs

0
Member Avatar myfairshare (< 20) Submitted: 8/17/2012 6:04:53 PM : Outperform Start Price: $6.16 PDLI Score: -17.21

I think the royalties are the best position to be in, for the pharmaceutical plays.

Recs

0
Member Avatar SamsaricSufferer (< 20) Submitted: 7/4/2012 8:35:17 PM : Outperform Start Price: $5.64 PDLI Score: -10.82

Biotech with solid pipeline

Featured Broker Partners


Advertisement